Patrys Ltd
ASX:PAB
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Eros International Media Ltd
NSE:EROSMEDIA
|
IN |
Patrys Ltd
Operating Income
Patrys Ltd
Operating Income Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Operating Income | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Patrys Ltd
ASX:PAB
|
Operating Income
-AU$4.5m
|
CAGR 3-Years
10%
|
CAGR 5-Years
-8%
|
CAGR 10-Years
5%
|
|
|
Mesoblast Ltd
ASX:MSB
|
Operating Income
-$73.4m
|
CAGR 3-Years
2%
|
CAGR 5-Years
8%
|
CAGR 10-Years
1%
|
|
|
CSL Ltd
ASX:CSL
|
Operating Income
$4B
|
CAGR 3-Years
11%
|
CAGR 5-Years
3%
|
CAGR 10-Years
9%
|
|
|
Race Oncology Ltd
ASX:RAC
|
Operating Income
-AU$8.2m
|
CAGR 3-Years
9%
|
CAGR 5-Years
-13%
|
CAGR 10-Years
N/A
|
|
|
Telix Pharmaceuticals Ltd
ASX:TLX
|
Operating Income
AU$30.9m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
PYC Therapeutics Ltd
ASX:PYC
|
Operating Income
-AU$46.4m
|
CAGR 3-Years
-23%
|
CAGR 5-Years
-35%
|
CAGR 10-Years
-23%
|
|
Patrys Ltd
Glance View
Patrys Ltd. engages in the commercialisation of the group's proprietary technologies to develop natural human antibody-based therapeutic products for the treatment of cancer and the pursuit of non-dilutive funding sources. The company is headquartered in South Melbourne, Victoria. The company went IPO on 2007-07-13. The firm is engaged in developing the treatment of Glioblastoma (GBM) and Triple Negative Breast Cancer (TNBC). The firm has developed two forms of deoxymab 3E10, including PAX-DX1 and PAT-DX3. Its is also using the PAT-DX1 antibody to deliver nanoparticles carrying therapeutic payloads to the inside of cells. The firm is in the process of the first human clinical trial of PAT-DX1. Its two product candidates, PAT-DX2 and PAT-DX1-NP are under preclinical stage.
See Also
What is Patrys Ltd's Operating Income?
Operating Income
-4.5m
AUD
Based on the financial report for Dec 31, 2025, Patrys Ltd's Operating Income amounts to -4.5m AUD.
What is Patrys Ltd's Operating Income growth rate?
Operating Income CAGR 10Y
5%
Over the last year, the Operating Income growth was -45%. The average annual Operating Income growth rates for Patrys Ltd have been 10% over the past three years , -8% over the past five years , and 5% over the past ten years .
